Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates

Pediatric Infectious Disease Journal

Volumn 31, Issue 12, 2012, Pages 1252-1257

  Steinbach, William J ^a,y   Roilides, Emmanuel ^b   Berman, David ^c   Hoffman, Jill A ^d   Groll, Andreas H ^e   Bin Hussain, Ibrahim ^f   Palazzi, Debra L ^g   Castagnola, Elio ^h   Halasa, Natasha ⁱ   Velegraki, Aristea ^j   Dvorak, Christopher C ^k   Charkabarti, Arunaloke ^l   Sung, Lillian ^m   Danziger Isakov, Lara ⁿ   Lachenauer, Catherine ^o   Arrieta, Antonio ^p   Knapp, Katherine ^q   Abzug, Mark J ^r   Ziebold, Christine ^s   Lehrnbecher, Thomas ^t   Klingspor, Lena ^u   Warris, Adilia ^v   Leckerman, Kateri ^w   Martling, Teresa ^a   Walsh, Thomas J ^x   Benjamin, Daniel K ^a   Zaoutis, Theoklis E ^w   more..

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^d CHILDREN S HOSPITAL LOS ANGELES   (United States)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^f KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^g TEXAS CHILDREN S HOSPITAL   (United States)

^h G GASLINI INSTITUTE   (Italy)

ⁱ VANDERBILT UNIVERSITY   (United States)

^j UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^m HOSPITAL FOR SICK CHILDREN   (Canada)

ⁿ LERNER RESEARCH INSTITUTE   (United States)

^o BOSTON CHILDREN S HOSPITAL   (United States)

^p CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^q ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^r UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^s UNIVERSITY OF IOWA CHILDREN S HOSPITAL   (United States)

^t GOETHE UNIVERSITY   (Germany)

^u KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^v RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^w CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^x WEILL CORNELL MEDICAL CENTER   (United States)

^y Division of Pediatric Infectious Disease   (United States)

more..

Author keywords

Antifungal; Epidemiology; Fungal; Invasive candidiasis; Pediatric

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; MICAFUNGIN; POLYENE ANTIBIOTIC AGENT; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ADOLESCENT; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CHILD; CONTROLLED STUDY; DRUG EFFICACY; EPIDEMIOLOGICAL DATA; FEMALE; FUNGAL STRAIN; GROUPS BY AGE; HUMAN; INVASIVE CANDIDIASIS; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NEPHROTOXICITY; NEWBORN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SKIN TOXICITY; TREATMENT RESPONSE;

ADOLESCENT; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS, INVASIVE; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC STUDIES; EUROPE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTERNATIONAL COOPERATION; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES;

EID: 84870861717     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182737427     Document Type: Article

References (29)

1. Wisplinghoff H, Seifert H, Tallent SM, et al. Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities. Pediatr Infect Dis J. 2003;22:686-691.
2. Raymond J, Aujard Y. Nosocomial infections in pediatric patients: a European, multicenter prospective study. European Study Group. Infect Control Hosp Epidemiol. 2000;21:260-263.
3. Zaoutis TE, Argon J, Chu J, et al. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis. 2005;41:1232-1239.
4. Roilides E, Kadiltsoglou I, Zahides D, et al. Invasive candidosis in pediatric patients. Clin Microbiol Infect. 1997;3:192-197.
5. Krcmery V, Laho L, Huttova M, et al. Aetiology, antifungal susceptibility, risk factors and outcome in 201 fungaemic children: data from a 12-year prospective national study from Slovakia. J Med Microbiol. 2002;51:110-116.
6. Zaoutis TE, Greves HM, Lautenbach E, et al. Risk factors for disseminated candidiasis in children with candidemia. Pediatr Infect Dis J. 2004;23:635-641.
7. Zaoutis TE, Coffin SE, Chu JH, et al. Risk factors for mortality in children with candidemia. Pediatr Infect Dis J. 2005;24:736-739.
8. Pasqualotto AC, de Moraes AB, Zanini RR, et al. Analysis of independent risk factors for death among pediatric patients with candidemia and a central venous catheter in place. Infect Control Hosp Epidemiol. 2007;28:799-804.
9. Neu N, Malik M, Lunding A, et al. Epidemiology of candidemia at a Children's hospital, 2002 to 2006. Pediatr Infect Dis J. 2009;28:806-809.
10. Zaoutis TE, Prasad PA, Localio AR, et al. Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention. Clin Infect Dis. 2010;51:e38-e45.
11. Tragiannidis A, Fegeler W, Rellensmann G, et al. Candidaemia in a European Paediatric University Hospital: a 10-year observational study. Clin Microbiol Infect. 2012;18:E27-E30.
12. Pappas PG, Rex JH, Lee J, et al.; NIAID Mycoses Study Group. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis. 2003;37:634-643.
13. Velasco E, Bigni R. A prospective cohort study evaluating the prognostic impact of clinical characteristics and comorbid conditions of hospitalized adult and pediatric cancer patients with candidemia. Eur J Clin Microbiol Infect Dis. 2008;27:1071-1078.
14. Blyth CC, Chen SC, Slavin MA, et al.; Australian Candidemia Study. Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics. 2009;123:1360-1368.
15. Zaoutis TE, Jafri HS, Huang LM, et al. A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients. Pediatrics. 2009;123:877-884.
16. Wiley JM, Seibel NL, Walsh TJ. Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections. Pediatr Infect Dis J. 2005;24:167-174.
17. Walsh TJ, Whitcomb P, Piscitelli S, et al. Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis. Antimicrob Agents Chemother. 1997;41:1944-1948.
18. Walsh TJ, Seibel NL, Arndt C, et al. Amphotericin B lipid complex in pediatric patients with invasive fungal infections. Pediatr Infect Dis J. 1999;18:702-708.
19. Würthwein G, Groll AH, Hempel G, et al. Population pharmacokinetics of amphotericin B lipid complex in neonates. Antimicrob Agents Chemother. 2005;49:5092-5098.
20. Queiroz-Telles F, Berezin E, Leverger G, et al.; Micafungin Invasive Candidiasis Study Group. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial. Pediatr Infect Dis J. 2008;27:820-826.
21. De Pauw B, Walsh TJ, Donnelly J P, et al.; European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813-1821.
22. Segal BH, Herbrecht R, Stevens DA, et al. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis. 2008;47:674-683.
23. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377-381.
24. Dotis J, Prasad PA, Zaoutis T, et al. Epidemiology, risk factors and outcome of Candida parapsilosis bloodstream infection in children. Pediatr Infect Dis J. 2012;31:557-560.
25. Benjamin DK Jr, Stoll BJ, Fanaroff AA, et al.; National Institute of Child Health and Human Development Neonatal Research Network. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics. 2006;117:84-92.
26. Dutta A, Palazzi DL. Candida non-albicans versus Candida albicans fungemia in the non-neonatal pediatric population. Pediatr Infect Dis J. 2011;30:664-668.
27. Ben-Ami R, Olshtain-Pops K, Krieger M, et al.; Israeli Candidemia Study Group. Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection. Antimicrob Agents Chemother. 2012;56:2518-2523.
28. Arendrup M, Horn T, Frimodt-Møller N. In vivo pathogenicity of eight medically relevant Candida species in an animal model. Infection. 2002;30:286-291.
29. Prasad PA, Coffin SE, Leckerman KH, et al. Pediatric antifungal utilization: new drugs, new trends. Pediatr Infect Dis J. 2008;27:1083-1088.